Mark Kamps - Publications

University of California, San Diego, La Jolla, CA 

73 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Zhu Y, Gong K, Denholtz M, Chandra V, Kamps MP, Alber F, Murre C. Comprehensive characterization of neutrophil genome topology. Genes & Development. PMID 28167501 DOI: 10.1101/gad.293910.116  0.44
2012 Miles LA, Lighvani S, Baik N, Andronicos NM, Chen EI, Parmer CM, Khaldoyanidi S, Diggs JE, Kiosses WB, Kamps MP, Yates JR, Parmer RJ. The plasminogen receptor, Plg-R(KT), and macrophage function. Journal of Biomedicine & Biotechnology. 2012: 250464. PMID 23125524 DOI: 10.1155/2012/250464  1
2012 Li D, Yang H, Nan H, Liu P, Pang S, Zhao Q, Karni R, Kamps MP, Xu Y, Zhou J, Wiedmer T, Sims PJ, Wang F. Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model. Blood. 120: 4712-9. PMID 23086752 DOI: 10.1182/blood-2012-03-414979  1
2011 Pasillas MP, Shah M, Kamps MP. NSD1 PHD domains bind methylated H3K4 and H3K9 using interactions disrupted by point mutations in human sotos syndrome. Human Mutation. 32: 292-8. PMID 21972110 DOI: 10.1002/humu.21424  1
2010 Andronicos NM, Chen EI, Baik N, Bai H, Parmer CM, Kiosses WB, Kamps MP, Yates JR, Parmer RJ, Miles LA. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood. 115: 1319-30. PMID 19897580 DOI: 10.1182/blood-2008-11-188938  1
2009 Scheele JS, Kolanczyk M, Gantert M, Zemojtel T, Dorn A, Sykes DB, Sykes DP, Möbest DC, Kamps MP, Räpple D, Duchniewicz M. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1. Leukemia & Lymphoma. 50: 816-28. PMID 19399691 DOI: 10.1080/10428190902836107  1
2009 Jürgens AS, Kolanczyk M, Moebest DC, Zemojtel T, Lichtenauer U, Duchniewicz M, Gantert MP, Hecht J, Hattenhorst U, Burdach S, Dorn A, Kamps MP, Beuschlein F, Räpple D, Scheele JS. PBX1 is dispensable for neural commitment of RA-treated murine ES cells. In Vitro Cellular & Developmental Biology. Animal. 45: 252-63. PMID 19148706 DOI: 10.1007/s11626-008-9162-5  1
2007 Wang GG, Cai L, Pasillas MP, Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nature Cell Biology. 9: 804-12. PMID 17589499 DOI: 10.1038/ncb1608  1
2007 Odegaard JI, Vats D, Zhang L, Ricardo-Gonzalez R, Smith KL, Sykes DB, Kamps MP, Chawla A. Quantitative expansion of ES cell-derived myeloid progenitors capable of differentiating into macrophages. Journal of Leukocyte Biology. 81: 711-9. PMID 17158607 DOI: 10.1189/jlb.0906590  1
2007 Lichtenauer UD, Duchniewicz M, Kolanczyk M, Hoeflich A, Hahner S, Else T, Bicknell AB, Zemojtel T, Stallings NR, Schulte DM, Kamps MP, Hammer GD, Scheele JS, Beuschlein F. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology. 148: 693-704. PMID 17082260 DOI: 10.1210/en.2006-0681  1
2007 Wang GG, Kamps MP. Survival signaling in HoxA9/Meis1 AML Blood. 109: 3619-3620. DOI: 10.1182/blood-2007-02-072785  1
2006 Wang GG, Pasillas MP, Kamps MP. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Molecular and Cellular Biology. 26: 3902-16. PMID 16648484 DOI: 10.1128/MCB.26.10.3902-3916.2006  1
2006 Wang GG, Calvo KR, Pasillas MP, Sykes DB, Häcker H, Kamps MP. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nature Methods. 3: 287-93. PMID 16554834 DOI: 10.1038/nmeth865  1
2006 Häcker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Häcker G, Mann M, Karin M. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 439: 204-7. PMID 16306937 DOI: 10.1038/nature04369  1
2005 Wang GG, Pasillas MP, Kamps MP. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood. 106: 254-64. PMID 15755900 DOI: 10.1182/blood-2004-12-4664  1
2004 Rave-Harel N, Givens ML, Nelson SB, Duong HA, Coss D, Clark ME, Hall SB, Kamps MP, Mellon PL. TALE homeodomain proteins regulate gonadotropin-releasing hormone gene expression independently and via interactions with Oct-1. The Journal of Biological Chemistry. 279: 30287-97. PMID 15138251 DOI: 10.1074/jbc.M402960200  1
2004 Sykes DB, Kamps MP. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice. Molecular and Cellular Biology. 24: 1256-69. PMID 14729970 DOI: 10.1128/MCB.24.3.1256-1269.2004  1
2003 Sykes DB, Scheele J, Pasillas M, Kamps MP. Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbx1 oncoprotein. Leukemia & Lymphoma. 44: 1187-99. PMID 12916872 DOI: 10.1080/1042819031000090273  1
2003 Sykes DB, Kamps MP. Estrogen-regulated conditional oncoproteins: tools to address open questions in normal myeloid cell function, normal myeloid differentiation, and the genetic basis of differentiation arrest in myeloid leukemia. Leukemia & Lymphoma. 44: 1131-9. PMID 12916864 DOI: 10.1080/1042819031000063444  1
2002 Calvo KR, Sykes DB, Pasillas MP, Kamps MP. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene. 21: 4247-56. PMID 12082612 DOI: 10.1038/sj.onc.1205516  1
2002 Klappacher GW, Lunyak VV, Sykes DB, Sawka-Verhelle D, Sage J, Brard G, Ngo SD, Gangadharan D, Jacks T, Kamps MP, Rose DW, Rosenfeld MG, Glass CK. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell. 109: 169-80. PMID 12007404 DOI: 10.1016/S0092-8674(02)00714-6  1
2001 Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 98: 13120-5. PMID 11687616 DOI: 10.1073/pnas.231115398  1
2001 Sykes DB, Kamps MP. Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins. Blood. 98: 2308-18. PMID 11588024 DOI: 10.1182/blood.V98.8.2308  1
2001 Knoepfler PS, Sykes DB, Pasillas M, Kamps MP. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation. Oncogene. 20: 5440-8. PMID 11571641 DOI: 10.1038/sj.onc.1204710  1
2000 Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Molecular and Cellular Biology. 20: 3274-85. PMID 10757811 DOI: 10.1128/MCB.20.9.3274-3285.2000  1
2000 Jaw TJ, You LR, Knoepfler PS, Yao LC, Pai CY, Tang CY, Chang LP, Berthelsen J, Blasi F, Kamps MP, Sun YH. Direct interaction of two homeoproteins, homothorax and extradenticle, is essential for EXD nuclear localization and function. Mechanisms of Development. 91: 279-91. PMID 10704852 DOI: 10.1016/S0925-4773(99)00316-0  1
1999 Calvo KR, Knoepfler P, McGrath S, Kamps MP. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene. 18: 8033-43. PMID 10637514 DOI: 10.1038/sj.onc.1203377  1
1999 Fu X, Roberts WG, Nobile V, Shapiro R, Kamps MP. mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family. Growth Factors (Chur, Switzerland). 17: 125-37. PMID 10595312  1
1999 Fu X, McGrath S, Pasillas M, Nakazawa S, Kamps MP. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1. Oncogene. 18: 4920-9. PMID 10490826 DOI: 10.1038/sj.onc.1202874  1
1999 Knoepfler PS, Bergstrom DA, Uetsuki T, Dac-Korytko I, Sun YH, Wright WE, Tapscott SJ, Kamps MP. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Research. 27: 3752-61. PMID 10471746 DOI: 10.1093/nar/27.18.3752  1
1997 Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proceedings of the National Academy of Sciences of the United States of America. 94: 14553-8. PMID 9405651 DOI: 10.1073/pnas.94.26.14553  1
1997 White FC, Benehacene A, Scheele JS, Kamps M. VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation--evidence for divergent stabilization pathways. Growth Factors (Chur, Switzerland). 14: 199-212. PMID 9255609  1
1997 Knoepfler PS, Kamps MP. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements. Oncogene. 14: 2521-31. PMID 9191052 DOI: 10.1038/sj.onc.1201097  1
1997 Knoepfler PS, Kamps MP. The Pbx family of proteins is strongly upregulated by a post-transcriptional mechanism during retinoic acid-induced differentiation of P19 embryonal carcinoma cells. Mechanisms of Development. 63: 5-14. PMID 9178252 DOI: 10.1016/S0925-4773(97)00669-2  1
1997 Kamps MP. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation. Current Topics in Microbiology and Immunology. 220: 25-43. PMID 9103673  1
1997 Fu X, Kamps MP. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Molecular and Cellular Biology. 17: 1503-12. PMID 9032278  1
1997 Lu Q, Kamps MP. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene. 14: 75-83. PMID 9010234 DOI: 10.1038/sj.onc.1200799  1
1997 Herold C, White F, McGrath S, Kamps MP. Constitutive stabilization of VEGF mRNA in human HT1080 fibrosarcoma cells is not mediated by mutations in 3 ′ UTR elements proposed to regulate mRNA stability Cardiovascular Pathobiology. 2: 88-96.  1
1996 Knoepfler PS, Lu Q, Kamps MP. Pbx-1 Hox heterodimers bind DNA on inseparable half-sites that permit intrinsic DNA binding specificity of the Hox partner at nucleotides 3' to a TAAT motif. Nucleic Acids Research. 24: 2288-94. PMID 8710498  1
1996 Lu Q, Kamps MP. Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: proposal for a model of a Pbx1-Hox-DNA complex. Molecular and Cellular Biology. 16: 1632-40. PMID 8657138  1
1996 Lu Q, Kamps MP. Selective repression of transcriptional activators by Pbx1 does not require the homeodomain. Proceedings of the National Academy of Sciences of the United States of America. 93: 470-4. PMID 8552663 DOI: 10.1073/pnas.93.1.470  1
1996 Kamps MP, Wright DD, Lu Q. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene. 12: 19-30. PMID 8552391  1
1996 White FC, Kamps M. Transcriptional Activation of the VEGF Gene by Okadaic Acid Qualitative Health Research. 6: 133-144.  1
1995 White FC, Carroll SM, Kamps MP. VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors (Chur, Switzerland). 12: 289-301. PMID 8930020 DOI: 10.3109/08977199509028967  1
1995 Peers B, Sharma S, Johnson T, Kamps M, Montminy M. The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Molecular and Cellular Biology. 15: 7091-7. PMID 8524276  1
1995 Lu Q, Knoepfler PS, Scheele J, Wright DD, Kamps MP. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Molecular and Cellular Biology. 15: 3786-95. PMID 7791786  1
1995 Ogo A, Waterman MR, Kamps MP, Kagawa N. Protein kinase A-dependent transactivation by the E2A-Pbx1 fusion protein. The Journal of Biological Chemistry. 270: 25340-3. PMID 7592695 DOI: 10.1074/jbc.270.43.25340  1
1995 Knoepfler PS, Kamps MP. The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1. Molecular and Cellular Biology. 15: 5811-9. PMID 7565734  1
1994 Wright DD, Sefton BM, Kamps MP. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia. Molecular and Cellular Biology. 14: 2429-37. PMID 8139546  1
1994 Kamps MP, Wright DD. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene. 9: 3159-66. PMID 7936638  1
1994 Lu Q, Wright DD, Kamps MP. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Molecular and Cellular Biology. 14: 3938-48. PMID 7910944  1
1993 Kamps MP, Baltimore D. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Molecular and Cellular Biology. 13: 351-7. PMID 8093327  1
1992 Privitera E, Kamps MP, Hayashi Y, Inaba T, Shapiro LH, Raimondi SC, Behm F, Hendershot L, Carroll AJ, Baltimore D. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood. 79: 1781-8. PMID 1348433  1
1991 Kamps MP. Determination of phosphoamino acid composition by acid hydrolysis of protein blotted to Immobilon. Methods in Enzymology. 201: 21-7. PMID 1719341  1
1991 Kamps MP. Generation and use of anti-phosphotyrosine antibodies for immunoblotting. Methods in Enzymology. 201: 101-10. PMID 1719339  1
1991 Kamps MP, Look AT, Baltimore D. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes & Development. 5: 358-68. PMID 1672117  1
1990 Kamps MP, Corcoran L, LeBowitz JH, Baltimore D. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Molecular and Cellular Biology. 10: 5464-72. PMID 2204815  1
1990 Kamps MP, Murre C, Sun XH, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 60: 547-55. PMID 1967983 DOI: 10.1016/0092-8674(90)90658-2  1
1989 Kamps MP, Sefton BM. Acid and base hydrolysis of phosphoproteins bound to immobilon facilitates analysis of phosphoamino acids in gel-fractionated proteins. Analytical Biochemistry. 176: 22-7. PMID 2540676 DOI: 10.1016/0003-2697(89)90266-2  1
1989 Cartwright CA, Kamps MP, Meisler AI, Pipas JM, Eckhart W. pp60c-src activation in human colon carcinoma. The Journal of Clinical Investigation. 83: 2025-33. PMID 2498394 DOI: 10.1172/JCI114113  1
1988 Stern DF, Kamps MP. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions. The Embo Journal. 7: 995-1001. PMID 3261240  1
1988 Sassone-Corsi P, Lamph WW, Kamps M, Verma IM. fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell. 54: 553-60. PMID 3135941 DOI: 10.1016/0092-8674(88)90077-3  1
1988 Kamps MP, Sefton BM. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Oncogene Research. 3: 105-15. PMID 2465525  1
1988 Stern DF, Kamps MP, Cao H. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo. Molecular and Cellular Biology. 8: 3969-73. PMID 2464744 DOI: 10.1128/MCB.8.9.3969  1
1988 Kamps MP, Sefton BM. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene. 2: 305-15. PMID 2452398  1
1988 Glenney JR, Zokas L, Kamps MP. Monoclonal antibodies to phosphotyrosine. Journal of Immunological Methods. 109: 277-85. PMID 2452204 DOI: 10.1016/0022-1759(88)90253-0  1
1986 Buss JE, Kamps MP, Gould K, Sefton BM. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity. Journal of Virology. 58: 468-74. PMID 3009860  1
1986 Kamps MP, Buss JE, Sefton BM. Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell. 45: 105-12. PMID 3006923 DOI: 10.1016/0092-8674(86)90542-8  1
1986 Kamps MP, Sefton BM. Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src. Molecular and Cellular Biology. 6: 751-7. PMID 2430174  1
1985 Kamps MP, Buss JE, Sefton BM. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proceedings of the National Academy of Sciences of the United States of America. 82: 4625-8. PMID 2991884  1
1985 Buss JE, Kamps MP, Sefton BM. Mutant p60(src)'s which lack myristic acid do not transform cells Federation Proceedings. 44: No. 4671.  1
1984 Buss JE, Kamps MP, Sefton BM. Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Molecular and Cellular Biology. 4: 2697-704. PMID 6441887  1
1984 Kamps MP, Taylor SS, Sefton BM. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites. Nature. 310: 589-92. PMID 6431300 DOI: 10.1038/310589a0  1
Show low-probability matches.